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The human disease landscape
The past few years have witnessed a growing number of 
well  documented  connections  between  and  among 
human  disease  phenotypes,  whose  relationship  would 
not have been obvious within the current disease classi­
fication framework. The evidence stems from a variety of 
sources,  spanning  clinical  epidemiology,  computational 
genomics and various model systems [1­5]. The implica­
tions are potentially so fundamental to disease etiology, 
drug development and the general diagnostic paradigm 
that there have been calls for an NIH Roadmap (large 
trans­institute  transformational  grants)  focused  on 
delineating the human disease landscape ­ a quantitative 
bipartite correlation map relating disease phenotypes and 
their  genetic  structures.  A  new  study  of  phenotype 
correlations [6] now takes this idea further.
One  of  the  earliest  comprehensive  studies  of  human 
phenotype correlations was by Rzhetsky et al. [5], who 
established a correlation network between 161 diseases 
and disorders using evidence of comorbidities obtained 
from  some  1.5  million  patient  records.  Among  other 
results, they found suggestive evidence for genetic rela­
tions between autism, which manifests in childhood, and 
several late onset diseases, including bipolar disorder and 
schizophrenia.
A different approach was taken by Goh et al. [1], who 
constructed a human disease network by linking genetic 
disorders that are known to share causative genes. The 
network  was  based  on  an  analysis  of  the  Online 
Mendelian  Inheritance  in  Man  (OMIM)  database,  the 
most  comprehensive  compendium  of  well  established 
associations  between  human  disorders  and  their  asso­
ciated genes [7]. Among their findings was a large subnet 
formed  by  516  of  the  1,284  disorders  studied,  clearly 
showing  many­to­many  relationships  between  pheno­
types and genes. For example, KRAS (encoding a small 
GTPase),  BRCA1  and  BRCA2  (both  encoding  tumor 
suppressors) are all involved in breast cancer, but KRAS 
is also implicated in pancreatic cancer, whereas BRCA1 
and BRCA2 are associated with papillary carcinoma and 
prostate cancer, respectively [7]. The results of these and 
other studies support the concept that genes underlying a 
disorder tend to be functionally related; for example, they 
could be part of a particular protein complex, a particular 
pathway  or  process,  or  a  particular  set  of  coexpressed 
genes. A disorder can then be viewed as a phenotype that 
emerges from dysfunction of one or more components of 
a  functionally  coherent  gene  module.  An  important 
aspect of modularization is that any gene in the module 
that was not previously identified with the phenotype is a 
candidate for association with it [8]. Moreover, a par  ticular 
module can, to varying extents, underlie related pheno­
types, opening up the possibility of linking phenotypes not 
only on the basis of shared genes, but also on the basis of 
functionally related genes that are not shared.
Inferring  disease  connectivity  through  functional 
linkage starts with a network of genes whose functions 
are  correlated;  that  is,  each  pair  of  nodes  (genes  or 
proteins)  is  connected  by  one  or  more  sources  of 
evidence  supporting  its  functional  coherence,  such  as 
physical interaction, correlated expression, adjacency in 
the same metabolic pathway or genetic interaction [2­4]. 
Connections can then be inferred between the diseases 
whose associated genes are linked in the gene network. 
For  instance,  we  and  our  colleagues  [3]  constructed  a 
network for the human genome by integration of diverse 
types of evidence using a Bayesian model, and annotated 
it with all OMIM disease genes for diseases known to be 
associated with five or more genes. Genes that are most 
tightly  linked  to  those  known  to  be  associated  with  a 
given  disease  are  immediate  candidates  for  association 
with  that  disease.  Furthermore,  connections  between 
disease pairs can be quantitatively identified on the basis 
of the magnitude of the functional linkage between their 
disease­associated  genes.  Thus,  two  diseases  can  be 
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The  associations  found  ranged  from  phenotypically 
disparate  disease  pairs,  such  as  multiple  sclerosis  with 
malaria, to phenotypically similar pairs, such as muscular 
dystrophy with myopathy. Such results suggest that the 
current  disease  classification  may  be  much  less 
informative than is commonly believed.
Recognition of molecular connections between disease 
phenotypes provides immediate insight into the molecular 
mechanisms  underlying  different  diseases  and  can 
therefore  generate  novel  hypotheses  for  therapeutic 
strategies. This is especially valuable if one disease is well 
studied and the other is not; it might also be valuable if 
viable drug targets have been found for one of the diseases 
but  not  the  other.  This  prospect  of  drug  repositioning 
could accelerate the introduction of therapies by years [9].
Human disease models and phenotypic 
connections in surprising places
Recent  work  from  Edward  Marcotte’s  laboratory  by 
McGary et al. [6] takes these concepts, and indeed the 
entire  field  of  phenomics,  to  an  entirely  new  level  by 
developing,  establishing  and  exploring  a  quantitative 
method to find non­obvious phenotypic connections, not 
just  within  a  species,  but  across  species.  Such  cross­
species  phenotypic  connections  stem  from  the  evolu­
tionary conservation of the underlying associated gene 
modules [8,10]. The importance of the work reported by 
McGary  et  al.  [6]  can  be  glimpsed  by  recalling  that 
whereas OMIM, which is the most extensive database of 
well  established  human  gene­phenotype  associations, 
contains approximately 5,400 unique associations [7], the 
numbers for some model organisms are 1 to 2 orders of 
magnitude higher [6]. Some of these relations ­ such as 
between obesity and its implicated genes in mice ­ have 
obvious equivalences in humans, and when they do, the 
laboratory model can serve as a useful surrogate to study 
the  disease  or  disorder.  Other  phenotypic  pairs  are 
entirely non­obvious, such as the fact that retinal cancer 
in humans and ectopic vulvae in the nematode can both 
be caused by disruption of the human retinoblastoma 1 
(RB1) gene or its nematode ortholog [6]. Because such 
non­obvious  relations  can  occur  with  surprising 
frequency,  a  method  that  can  rapidly  and  reliably  link 
human  genes  to  non­obviously  related  phenotypes  in 
model  systems  offers  the  prospect  of  radically 
accelerating  the  rate  at  which  we  can  explore  disease 
landscapes in both humans and model organisms.
McGary et al. [6] provide more than a glimpse at the 
possibilities. They begin by defining ‘phenologs’ as cross­
species  mutant  phenotypes  that  share  a  significant 
number of orthologous genes. The statistical significance 
of phenologs, whose emergence results from disruption 
of orthologous genes, can be estimated as the probability 
that the observed number of orthologues common to the 
two phenotypes would be found by chance and correcting 
for multiple hypotheses. In this way, using approximately 
300 human diseases and over 6,000 phenotypes in model 
organisms, including mouse, worm, yeast and Arabidopsis, 
they identify 4,390 significant phenologs. As one of the 
positive controls, the authors note that the 3,755 mouse­
human phenologs identified contain many of the known 
disease models ­ including cataracts, deafness and retinal 
disease  ­  all  at  P­values  well  below  10­8.  Given  that 
phenologs map gene­phenotype associations across the 
phyla, an association known in one species can be used 
to  find  non­established  relations  in  another.  Cross­
validations  presented  by  McGary  et  al.  [6]  show  that 
phenologs  can  predict  genes  associated  with  about  a 
third to a half of tested human diseases.
The  work  [6]  offers  tantalizing  evidence  for  several 
counterintuitive  mammalian  disease  models,  including 
reduced growth rate of yeast deletion strains in medium 
enriched with the cholesterol­lowering drug lovastatin as 
a model for abnormal angiogenesis in mice, and negative 
gravitropism defects in Arabidopsis as a model for human 
Waardenburg  syndrome  (which  causes  deafness  with 
defects  in  neural­crest­derived  tissues).  Furthermore, 
using  the  yeast  model,  they  demonstrate  that  SOX13 
(encod  ing  a  transcription  factor  related  to  the  sex­
determining  gene  SRY)  is  a  new  gene  that  regulates 
angiogenesis, and using the Arabidopsis model they show 
that  SEC23IP  (encoding  a  protein  that  interacts  with 
SEC23, a component of the COPII complex that controls 
endoplasmic reticulum­to­Golgi trafficking) is probably a 
new Waardenburg syndrome gene. Notwithstanding the 
fact that many functionally coherent gene modules are 
conserved  across  different  species  [10],  such  demon­
strations ­ especially the identification of phenologs that 
predate kingdom divergence ­ seem to mark one of those 
uncommon occasions in science in which intuition built 
on years of experience fails completely.
Additional connections
As staggering as these results [6] are, it seems possible 
that  many  phenologs  have  been  missed,  because  the 
method is confined to connections based only on pheno­
type  pairs  sharing  known  orthologous  genes.  Gene­
pheno  type  association  data  may,  however,  be  far  from 
complete;  if  so,  many  orthologous  phenotypes  will  be 
missed. One possible way to increase the discovery rate 
would be to consider the functional relatedness for the 
genes  associated  with  each  phenotype.  As  described 
earlier,  gene­gene  functional  relatedness  has  been 
success  fully  used  to  identify  phenotypic  connections 
within the same species [2­4], and it is possible that the 
same  principle  can  be  applied  to  identify  phenotype 
connections between different species.
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the impact of McGary et al. [6] on efforts to develop a 
more  complete  picture  of  the  topology  of  the  human 
phenome.  It  is  evident  that  the  way  phenomics  looks 
today,  the  amount  of  information  and  the  incredible 
interconnectivities, could not have been imagined even 
3 years ago. It seems likely that the methods developed 
and  demonstrated  by  McGary  et  al.  [6],  and  their 
inevitable extensions, will add unprecedented knowledge 
and quantitative detail to the interrelated landscapes of 
mutant phenotypes for humans and other species, and 
this will offer many more surprising correlations between 
and among human diseases. As our picture of the human 
disease landscape continues to take shape, perhaps the 
one thing that we should not be surprised about will be 
the  need  to  fundamentally  rethink  the  current  disease 
classification and its associated diagnostic paradigm.
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